T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 81 filers reported holding T2 BIOSYSTEMS INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -25.0% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | -57.9% | 50,000 | 0.0% | 0.00% | -75.0% |
| Q1 2022 | $19,000 | -26.9% | 50,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $26,000 | -44.7% | 50,000 | -2.9% | 0.01% | -53.8% |
| Q3 2021 | $47,000 | -23.0% | 51,500 | 0.0% | 0.01% | -31.6% |
| Q2 2021 | $61,000 | -7.6% | 51,500 | +1.6% | 0.02% | -29.6% |
| Q1 2021 | $66,000 | +6.5% | 50,675 | +1.4% | 0.03% | -3.6% |
| Q4 2020 | $62,000 | -6.1% | 50,000 | 0.0% | 0.03% | -22.2% |
| Q3 2020 | $66,000 | -13.2% | 50,000 | 0.0% | 0.04% | -25.0% |
| Q2 2020 | $76,000 | +216.7% | 50,000 | +25.0% | 0.05% | +200.0% |
| Q1 2020 | $24,000 | +100.0% | 40,000 | +300.0% | 0.02% | +128.6% |
| Q4 2019 | $12,000 | -50.0% | 10,000 | 0.0% | 0.01% | -56.2% |
| Q3 2019 | $24,000 | +41.2% | 10,000 | 0.0% | 0.02% | +33.3% |
| Q2 2019 | $17,000 | -34.6% | 10,000 | 0.0% | 0.01% | -36.8% |
| Q1 2019 | $26,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,875,524 | $9,865,000 | 11.71% |
| Aisling Capital LLC | 2,830,992 | $14,891,000 | 3.46% |
| Flagship Pioneering Inc. | 1,950,583 | $10,260,000 | 3.34% |
| Lagoda Investment Management, L.P. | 1,733,083 | $9,116,000 | 3.13% |
| TIGER MANAGEMENT L.L.C. | 1,364,085 | $7,175,000 | 1.30% |
| Senvest Management, LLC | 2,164,233 | $11,384,000 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 78,606 | $413,000 | 0.07% |
| WOODSTOCK CORP | 31,014 | $163,000 | 0.03% |
| Point72 Asset Management, L.P. | 367,009 | $1,930,000 | 0.01% |
| GOLDMAN SACHS GROUP INC | 4,252,616 | $22,369,000 | 0.01% |